An interventional study of LEAD IT! Programming in Dementia, Vascular, Alzheimer Disease and Dementia, Mixed, sponsored by Hopeful Aging. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-02.
Sponsored by Hopeful Aging · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 65 studies in Dementia, Vascular with a site in United States — 16 open to participants now, 20 under way, none of them phase 3. Dementia, Vascular · United States.
Among the 65 studies in Dementia, Vascular with a site in United States, this one is the 19th largest by enrollment of the 47 interventional ones that give a count, is one of 6 that started in 2020, is one of 33 with no phase, and was the 44th registered.
183 studies on the registry are indexed under Dementia, Vascular; 42 are open to participants now.
Browse Dementia, Vascular studies →16 of the 65 studies in Dementia, Vascular with a site in United States are open now. Recruiting first, the newest first:
Hopeful Aging · Sites in United States
Ages 18–103 · Healthy volunteers
Hopeful Aging · Sites in United States
Ages 65+
Herrick Medical LLC · Sites in United States
Ages 50–100
Center for Clinical Studies, Texas · Sites in United States
Ages 18+ · Healthy volunteers
Jasmohan Bajaj · Sites in United States
Ages 65+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 35 Dementia, Vascular studies recruiting now, 25 (71%) set no upper age limit and 2 (6%) stop at 75 or younger; 4 take children under 18; 13 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
65 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 5 · Phase 3 5 · Phase 4 2
First in 1995; this study’s year is marked. 6 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 182 is above the median of 123 across 116 interventional studies indexed under Dementia, Vascular.
Median enrollment 100 across the 47 interventional studies, 375 across the 17 observational. Of the 41 that completed or were terminated, 20 (49%) have results posted.
This tab as a report to print or save as PDF → With an account.
21 of 65 have an industry lead sponsor. The 10 most frequent:
Hopeful Aging is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
Hopeful Aging has 6 studies filed under Dementia, Vascular — fewer than ten, so there is no comparison to draw.
10 of the studies in Dementia, Vascular with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06298474Hopeful AgingThe BRAIN App (Phase 2 SBIR) | 2026-11-30 |
| NCT06034509Walter Reed National Military Medical CenterCognitive and Vascular Functioning Following TBI | 2027-01 |
| NCT03702907Georgetown UniversityDC Longitudinal Study on Aging and Specimen Bank | 2027-01 |
| NCT05704309Marinella TemprosaThe Diabetes Prevention Program Outcomes Study AD/ADRD Project | 2027-01-31 |
| NCT06079216Hopeful AgingMaking Connections Thru Music | 2027-04-29 |
Add all 10 to your calendar (.ics) → With an account.
Among the 65 studies in Dementia, Vascular with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The proposed Phase 2 project will involve the further development and evaluation of LEAD IT!, which is a tablet-based app designed to enable persons with dementia to lead activities for their peers (i.e., other persons with dementia). The study will examine the clinical outcomes of long-term use of the app by both Resident Leaders (RLs) and Resident Players (RPs).
The Specific Aims of the proposed Phase 2 project are to:
he proposed Phase 2 project will involve the further development and evaluation of LEAD IT!, as well as examine the clinical outcomes of long-term use of the app by both RLs and RPs.
The Specific Aims of the proposed Phase 2 project are to:
Inclusion Criteria for Persons with Dementia
Exclusion Criteria for Persons with Dementia -the person shows signs of rapid cognitive decline or physical deterioration over the last six months, as evidenced by medical records.
Inclusion Criteria for Staff
Exclusion Criteria for Staff
-n/a
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in the Experimental / LEAD IT! arm will take part in LEAD IT! programming for 18 weeks. The programming will occur twice per week, for a total of 36 sessions.
Behavioral: LEAD IT! Programming
Participants in the Control arm will receive standard care / programming.
LEAD IT! is an intervention that enables persons with dementia to lead activities for their peers. The activities take place on tablets.
Change From Baseline to Treatment for Constructive Engagement on the Menorah Park Engagement Scale [Time Frame: Baseline (Month 1) and Treatment (Months 2, 3, and 4)
Constructive Engagement on the Menorah Park Engagement Scale is defined as doing or commenting on something related to the target activity. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Constructive Engagement is zero (0) and the maximum score is two (2). Higher scores represent a better outcome.
Time frame: Baseline (Month 1) and Treatment (Months 2, 3, and 4)
Change From Baseline to Treatment for Passive Engagement on the Menorah Park Engagement Scale
Passive Engagement on the Menorah Park Engagement Scale is defined as listening or watching something related to the target activity.During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Passive Engagement is zero (0) and the maximum score is two (2). Higher scores represent a better outcome..
Time frame: Baseline (Month 1) and Treatment (Months 2, 3, and 4)
Change From Baseline to Treatment for Other Engagement on the Menorah Park Engagement Scale
Other Engagement on the Menorah Park Engagement Scale is defined as doing, commenting, listening, or watching something NOT related to the target activity. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Other Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.
Time frame: Baseline (Month 1) and Treatment (Months 2, 3, and 4)
Change From Baseline to Treatment for Non Engagement on the Menorah Park Engagement Scale
Non-Engagement on the Menorah Park Engagement Scale is defined as sleeping and/or staring into space. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Non-Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.
Time frame: Baseline (Month 1) and Treatment (Months 2, 3, and 4)
Change From Baseline to Treatment for Pleasure on the Menorah Park Engagement Scale
Pleasure on the Menorah Park Engagement Scale is defined as clearly observable laughing or smiling. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Pleasure is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.
Time frame: Baseline (Month 1) and Treatment (Months 2, 3, and 4)
Change From Baseline to Treatment on Dementia Related Quality of Life (DEMQOL)
The Dementia Related Quality of Life Scale is a 28 item scale that examines quality of life in persons with dementia. The score ranges for 28 to 112. Higher scores represent a better outcome.
Time frame: Baseline (Month 1) and Post-Treatment (Month 4)
Change From Baseline to Treatment on the Neuropsychiatric Inventory-Nursing Home (NPI-NH), Frequency x Severity Score (FxS)
The NPI-NH examines 10 types of neuropsychiatric symptoms in persons with dementia, with the FxS score looking creating a composite score that takes into account frequency and severity of the symptoms. The score ranges from 0 to 120. Lower scores represent a better outcome.
Time frame: Baseline (Month 1) and Post-Treatment (Month 4)
Change From Baseline to Treatment on the Geriatric Depression Scale-Short Form (GDS-SF)
The GDS-SF consists of 15 questions requiring "yes" or "no" answers. It is specifically developed for use with older adults. For persons unable to answer the questions, a proxy can be used. The total score ranges from 0 to 15, with lower scores indicating a better outcome.
Time frame: Baseline (Month 1) and Post-Treatment (Month 4)
Change From Baseline to Treatment on the Cohen Mansfield Agitation Inventory (CMAI)
The 14-item CMAI is a caregiver rated questionnaire using a 5-point Likert scale to rate the frequency of disturbing behaviors in dementia such as verbal/physical aggression, general restlessness, strange noises, and so on. Scores range from 14 to 70, with lower scores indicating a better outcome.
Time frame: Baseline (Month 1) and Post-Treatment (Month 4)
| Milestone | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| Started | 54 | 41 |
| Completed | 54 | 41 |
| Not completed | 0 | 0 |
| Milestone | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| Started | 54 | 41 |
| Completed | 51 | 37 |
| Not completed | 3 | 4 |
| Milestone | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| Started | 51 | 37 |
| Completed | 47 | 35 |
| Not completed | 4 | 2 |
Constructive Engagement on the Menorah Park Engagement Scale is defined as doing or commenting on something related to the target activity. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Constructive Engagement is zero (0) and the maximum score is two (2). Higher scores represent a better outcome.
| score on a scale | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| Change From Baseline to Treatment for Constructive Engagement on the Menorah Park Engagement Scale [Time Frame: Baseline (Month 1) and Treatment (Months 2, 3, and 4) | 0.19 ± 0.53 | -0.24 ± 0.50 |
Passive Engagement on the Menorah Park Engagement Scale is defined as listening or watching something related to the target activity.During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Passive Engagement is zero (0) and the maximum score is two (2). Higher scores represent a better outcome..
| score on a scale | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| Change From Baseline to Treatment for Passive Engagement on the Menorah Park Engagement Scale | 0.69 ± 0.65 | -0.12 ± 0.55 |
Other Engagement on the Menorah Park Engagement Scale is defined as doing, commenting, listening, or watching something NOT related to the target activity. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Other Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.
| score on a scale | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| Change From Baseline to Treatment for Other Engagement on the Menorah Park Engagement Scale | -0.32 ± 0.48 | 0.28 ± 0.50 |
Non-Engagement on the Menorah Park Engagement Scale is defined as sleeping and/or staring into space. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Non-Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.
| score on a scale | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| Change From Baseline to Treatment for Non Engagement on the Menorah Park Engagement Scale | -.24 ± 0.35 | 0.02 ± 0.41 |
Pleasure on the Menorah Park Engagement Scale is defined as clearly observable laughing or smiling. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Pleasure is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.
| score on a scale | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| Change From Baseline to Treatment for Pleasure on the Menorah Park Engagement Scale | 0.32 ± 0.25 | -0.02 ± 0.27 |
The Dementia Related Quality of Life Scale is a 28 item scale that examines quality of life in persons with dementia. The score ranges for 28 to 112. Higher scores represent a better outcome.
| score on scale | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| Change From Baseline to Treatment on Dementia Related Quality of Life (DEMQOL) | 1.51 ± 11.75 | 1.08 ± 15.39 |
The NPI-NH examines 10 types of neuropsychiatric symptoms in persons with dementia, with the FxS score looking creating a composite score that takes into account frequency and severity of the symptoms. The score ranges from 0 to 120. Lower scores represent a better outcome.
| score on scale | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| Change From Baseline to Treatment on the Neuropsychiatric Inventory-Nursing Home (NPI-NH), Frequency x Severity Score (FxS) | -0.15 ± 15.32 | 3.06 ± 9.04 |
The GDS-SF consists of 15 questions requiring "yes" or "no" answers. It is specifically developed for use with older adults. For persons unable to answer the questions, a proxy can be used. The total score ranges from 0 to 15, with lower scores indicating a better outcome.
| score on scale | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| Change From Baseline to Treatment on the Geriatric Depression Scale-Short Form (GDS-SF) | -0.71 ± 2.73 | 0.38 ± 4.58 |
The 14-item CMAI is a caregiver rated questionnaire using a 5-point Likert scale to rate the frequency of disturbing behaviors in dementia such as verbal/physical aggression, general restlessness, strange noises, and so on. Scores range from 14 to 70, with lower scores indicating a better outcome.
| score on scale | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| Change From Baseline to Treatment on the Cohen Mansfield Agitation Inventory (CMAI) | -0.21 ± 4.53 | 2.00 ± 7.57 |
Collected over 5 months. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Persons With Dementia, Experimental (LEAD IT! Programming) | 2/54 (3.7%) | 4/54 (7.4%) | 0/54 (0%) |
| Persons With Dementia, Control (Standard Care / Activity Programming) | 4/41 (9.8%) | 7/41 (17.1%) | 0/41 (0%) |
| Event | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) |
|---|---|---|
| DeathInjury, poisoning and procedural complications | 2/54 | 4/41 |
| Acute Illness or Injury, Sent to hospitalInjury, poisoning and procedural complications | 2/54 | 3/41 |
| Age, Categorical(Participants) | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 0 | 0 | 0 |
| >=65 years | 54 | 41 | 95 |
| Age, Continuous(years) | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) | Total |
|---|---|---|---|
| Mean | 87.13 ± 7.39 | 86.54 ± 7.06 | 86.87 ± 7.21 |
| Sex: Female, Male(Participants) | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) | Total |
|---|---|---|---|
| Female | 47 | 26 | 73 |
| Male | 7 | 15 | 22 |
| Ethnicity (NIH/OMB)(Participants) | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) | Total |
|---|---|---|---|
| Hispanic or Latino | 0 | 0 | 0 |
| Not Hispanic or Latino | 54 | 41 | 95 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 1 | 0 | 1 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 7 | 1 | 8 |
| White | 46 | 40 | 86 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Region of Enrollment(participants) | Persons With Dementia, Experimental (LEAD IT! Programming) | Persons With Dementia, Control (Standard Care / Activity Programming) | Total |
|---|---|---|---|
| United States | 54 | 41 | 95 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Undecided
Ran from Nov 2020 to primary completion in Jun 2023, 31 months.
Results were first posted in Dec 2024, 1 year 5 months after primary completion.
Of 53 interventional studies with no phase under Dementia, Vascular, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 53. This study's 31 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hopeful Aging